Mark Sabag - May 11, 2021 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Human Resources Officer and Corporate Brand and Communications
Signature
/s/ Dov Bergwerk as attorney-in-fact for Mark Sabag
Stock symbol
TEVA
Transactions as of
May 11, 2021
Transactions value $
$0
Form type
4
Date filed
5/13/2021, 07:46 AM
Next filing
Feb 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +37.9K +183.92% 58.5K May 11, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -37.9K -100% $0.00* 0 May 11, 2021 Ordinary Shares 37.9K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on February 9, 2021 pursuant to the satisfaction of performance criteria and vested on May 11, 2021.

Remarks:

EVP, Chief Human Resources Officer and Corporate Brand and Communications